Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?

PURPOSE: The long-term effectiveness of BNT162b2/Pfizer vaccine remains undetermined. This observational prospective study was designed to verify durability of antibodies against the viral receptor-binding domain (RBD) spike (S)-protein (RBD S-Protein IgG) after the second-dose administration of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stellini, Roberto, Gianello, Renzo, Gomarasca, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989116/
https://www.ncbi.nlm.nih.gov/pubmed/35391649
http://dx.doi.org/10.1007/s15010-022-01816-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989116/
https://www.ncbi.nlm.nih.gov/pubmed/35391649
http://dx.doi.org/10.1007/s15010-022-01816-9

Ejemplares similares